Murray Stewart's Net Worth
$270 Thousand
Who is Murray Stewart?
Murray Stewart does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., NOVELION THERAPEUTICS INC., X4 Pharmaceuticals, Inc, and AMARIN CORP PLC\UK.
SEC CIK
Murray Stewart's CIK is 0001723450
Past Insider Trading and Trends
2020 was Murray Stewart's most active year for acquiring shares with 4 total transactions. Murray Stewart's most active month to acquire stocks was the month of January. 2023 was Murray Stewart's most active year for disposing of shares, totalling 1 transactions. Murray Stewart's most active month to dispose stocks was the month of July. 2021 saw Murray Stewart paying a total of $57,000.00 for 71,625 shares, this is the most they've acquired in one year. In 2023 Murray Stewart cashed out on 130,056 shares for a total of $137,859.36, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVELION THERAPEUTICS INC. No price found
Executive Vice President, R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Nov 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
X4 Pharmaceuticals, Inc (XFOR) Snapshot price: $0.6887
Interim Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +30.72% | 45K |
—
|
—
| 191.5K |
Jun 10
| |||
Form 4
| +2,097.45% | 139.84K |
$1.06 | -$137,859.36 | 146.5K |
Aug 9 - Aug 10
| |||
Form 4
|
∞
| 6.67K |
—
|
—
| 6.67K |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMARIN CORP PLC\UK (AMRN) Snapshot price: $0.6094
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||